The cerebral iron overload in hemodialysis patients has been reported in a previous study, in which the evaluation of the changes in iron content could be affected by the cross‐sectional analysis.
To investigate the longitudinal changes of iron deposition in hemodialysis patients using quantitative susceptibility mapping (QSM) and correlate these findings with the longitudinal changes of neurocognitive function and clinical factors.
In all, 34 patients and 30 healthy controls (HCs); the mean follow‐up interval was 22 ± 7 months.
3.0T, susceptibility‐weighted imaging (SWI).
QSM reconstructed from original phase data of SWI was used to measure the susceptibility of gray matter structures including bilateral caudate nucleus (CN), globus pallidus (GP), putmen (PUT), red nucleus (RN), substantia nigra (SN), dentate nucleus (DN), thalamus (THA), pulvinar of thalamus (PT). The Mini‐Mental State Examination (MMSE) test and clinical factors were recorded.
Analysis of covariance adjusting for age and gender as covariates or a paired
t‐test for the differences in susceptibility, MMSE scores, and clinical factors among baseline, follow‐up patients, and HCs. Correlation and stepwise regression analysis for the relationship between susceptibility, MMSE scores, and clinical factors. Results
The susceptibility of bilateral CN, GP, PUT, RN, SN, DN, THA, PT in follow‐up patients was significantly higher than that in baseline between patients and HCs except for left THA (all
P< 0.05; Bonferroni corrected). MMSE scores significantly negatively correlated with the susceptibility of bilateral CN, PUT, and RRN in the baseline examination and bilateral CN, PUT, RN, and DN in the follow‐up examination (all P< 0.05; false discovery rate [FDR] corrected). The follow‐up interval, creatinine, phosphorus, and calcium were independent factors for the increased susceptibility of some nuclei (all P< 0.05). Data Conclusion
The iron deposition of gray matter nuclei in hemodialysis patients increased over roughly a 2‐year period and may be a risk factor for neurocognitive impairment. Creatinine and abnormal calcium‐phosphorus metabolism were independent risk factors for abnormal iron deposition.
Level of Evidence:2 Technical Efficacy:Stage 1
J. Magn. Reson. Imaging 2019;49:786–799.